Literature DB >> 7091131

The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.

R Perrillo, C Campbell, W Wellinghoff, L Gelb.   

Abstract

The purpose of this study was to examine the association of circulating viral markers with ongoing liver disease in chronic hepatitis B virus infection. Hepatitis B e antigen (HBeAg) was significantly more likely to be associated with abnormal alanine aminotransferase (ALT) activity than was anti-HBe in a group of 102 HBsAg carriers (p less than 0.0001). Within this group, 57 carriers were analyzed for HBeAg, DNA polymerase, and hepatitis B surface antigen (HBsAg) titer, and the relation of each with abnormal ALT was determined. Both HBeAg and elevated DNA polymerase were much more likely to reflect abnormal ALT (p less than 0.00001 and 0.0006, respectively) than did HBsAg titer. Unlike previous studies, higher titers of HBsAg would not be demonstrated in healthy carriers when compared to HBsAg carriers with chronic elevation of ALT; nor were differences in titer appreciated between chronic active and chronic persistent hepatitis. The potential significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7091131

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

Review 1.  Hepatitis B virology for clinicians.

Authors:  Edward C Doo; Marc G Ghany
Journal:  Clin Liver Dis       Date:  2010-08       Impact factor: 6.126

2.  Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases.

Authors:  S Kashiwagi; J Hayashi; H Ikematsu; H Nomura; W Kajiyama; T Shingu; K Hayashida; M Kaji
Journal:  Gastroenterol Jpn       Date:  1988-04

Review 3.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

Review 4.  Viral Biomarkers in Chronic HBeAg Negative HBV Infection.

Authors:  Emilia Hadziyannis; Andreas Laras
Journal:  Genes (Basel)       Date:  2018-09-27       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.